Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Pilot Study of the Feasibility and Safety of a Personalized Peptide Vaccine in Patients With Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02600949
Title field or adapter rule
{'original_value': 'Pilot Study of the Feasibility and Safety of a Personalized Peptide Vaccine in Patients With Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:23.579789+00:00
Published At
2026-10-13T00:00:00+00:00
Record Updated At
2026-10-13
Source Retrieved At
2026-10-31T22:17:52.415050+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Metastatic Colorectal Adenocarcinoma", "Metastatic Pancreatic Ductal Adenocarcinoma", "Stage IV Colorectal Cancer AJCC v7", "Stage IV Pancreatic Cancer AJCC v6 and v7", "Stage IVA Colorectal Cancer AJCC v7", "Stage IVB Colorectal Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-10-13", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT02600949"
protocolSection.identificationModule.officialTitle
"Pilot Study of the Feasibility and Safety of a Personalized Peptide Vaccine in Patients With Advanced Pancreatic Ductal Adenocarcinoma or Colorectal Adenocarcinoma"
protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Metastatic Colorectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer AJCC v6 and v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Colorectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Cohort A (personalized vaccine, imiquimod)', 'Cohort B (personalized vaccine, imiquimod, pembrolizumab)', 'Cohort C and D (vaccine, imiquimod, pembrolizumab, APX005M)'], 'description': 'Applied topically', 'name': 'Imiquimod', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort B (personalized vaccine, imiquimod, pembrolizumab)', 'Cohort C and D (vaccine, imiquimod, pembrolizumab, APX005M)'], 'description': 'Given IV', 'name': 'Pembrolizumab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort C and D (vaccine, imiquimod, pembrolizumab, APX005M)'], 'description': 'Given IV', 'name': 'Sotigalimab', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (personalized vaccine, imiquimod)', 'Cohort B (personalized vaccine, imiquimod, pembrolizumab)', 'Cohort C and D (vaccine, imiquimod, pembrolizumab, APX005M)'], 'description': 'Given SC', 'name': 'Synthetic Tumor-Associated Peptide Vaccine Therapy', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (personalized vaccine, imiquimod)', 'Cohort B (personalized vaccine, imiquimod, pembrolizumab)', 'Cohort C and D (vaccine, imiquimod, pembrolizumab, APX005M)'], 'description': 'Undergo CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Cohort A (personalized vaccine, imiquimod)', 'Cohort B (personalized vaccine, imiquimod, pembrolizumab)', 'Cohort C and D (vaccine, imiquimod, pembrolizumab, APX005M)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Imiquimod (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.